Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective

OBJECTIVE: To examine reasons why rheumatoid arthritis patients discontinued subcutaneous (SQ) anti-tumor necrosis factor (anti-TNF) treatment in the past 12 months, so as to help inform successful, uninterrupted therapy. METHODS: Data were collected in March and April 2011 using self-reported, inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolge, Susan C, Goren, Amir, Tandon, Neeta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309782/
https://www.ncbi.nlm.nih.gov/pubmed/25653505
http://dx.doi.org/10.2147/PPA.S70834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309782/
https://www.ncbi.nlm.nih.gov/pubmed/25653505
http://dx.doi.org/10.2147/PPA.S70834

Ejemplares similares